Table 3 Univariate analysis of clinicopathologic variables for ovarall survival rate

Age (> 11 years vs. ≦ 11 years)

0.001*

Tumor size (> 3 cm vs. ≦ 3 cm)

0.042*

Tubular formation (> 10% vs. ≦ 10%)

<0.001*

Nuclear pleomorphism (high vs. low)

0.044*

Mitotic count (> 11 vs. ≦ 10/10 HPFs)

0.005*

Histologic grade (3 vs. 2 and 1)

<0.001*

Lymphovascular invasion (yes vs. no)

<0.001*

Necrosis (extensive vs. limited/no)

0.004*

Estrogen receptor (negative vs. positive)

0.180

Her2/neu overexpression (positive vs. negative)

0.348

Beclin-1 cytoplasmic expression (low vs. high)

<0.001*

Beclin-1 nuclear expression (low vs. high)

0.074